Approval · Notice of Compliance 5489 · 1994
ZANTEFF: Notice of Compliance 5489
Issued March 11, 1994
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5489
- Date
- March 11, 1994
- Company
- Glaxo Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Histamine h2-receptor antagonist
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ZANTEFF | 02076284 | — |
| ZANTEFF | 02076292 | — |
| ZANTEFF | 01951831 | — |
| ZANTEFF | 01951823 | — |
Medicinal ingredients
- RANITIDINE HCL 150 MG per TAB
- RANITIDINE HCL 300 MG per TAB
- RANITIDINE HCL 150 MG per PCK
- RANITIDINE HCL 300 MG per PCK